Appendix D

Registered Attendees

Reza Alavi

Center for Medical Technology Policy

William Albuquerque

Genetic Alliance

C. Anthony Altar

AssureRx Health, Inc.

Eric Assaraf

Washington Research Group

David Bachinsky

Alpha-Genics

Judith Benkendorf

American College of Medical Genetics and Genomics

Sharon Bergquist

National Academy of Sciences

Paul Billings

Life Technologies

Bruce Blumberg

Kaiser Permanente

Juli Bollinger

Genetics and Public Policy Center

Denise Bonds

National Heart, Lung, and Blood Institute

Khaled Bouri

U.S. Food and Drug Administration

Chandra Branham

AdvaMed

Joel Brill

Predictive Health, LLC

Steven Brotman

AdvaMed

Jonca Bull

Novartis



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement



Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.

OCR for page 79
Appendix D Registered Attendees Reza Alavi Bruce Blumberg Center for Medical Technology Kaiser Permanente Policy Juli Bollinger William Albuquerque Genetics and Public Policy Center Genetic Alliance Denise Bonds C. Anthony Altar National Heart, Lung, and Blood AssureRx Health, Inc. Institute Eric Assaraf Khaled Bouri Washington Research Group U.S. Food and Drug Administration David Bachinsky Chandra Branham Alpha-Genics AdvaMed Judith Benkendorf Joel Brill American College of Medical Genetics and Genomics Predictive Health, LLC Sharon Bergquist Steven Brotman National Academy of Sciences AdvaMed Paul Billings Jonca Bull Life Technologies Novartis 79

OCR for page 79
80 GENOME-BASED DIAGNOSTICS Wylie Burke Jonathan Gitlin University of Washington National Human Genome Research Institute Khatereh Calleja Judith Glassgold AdvaMed Office of Rep. Sander Levin C. Thomas Caskey Joseph Glick Baylor College of Medicine Expertool Software Niranjana Chandrasekaran Federico Goodsaid Genetic Alliance Vertex Pharmaceuticals John Cogswell Mark Gorman Bristol-Myers Squibb National Coalition for Cancer Nicholas Conti Survivorship Quest Diagnostics Johanna Gray Sara Copeland CRD Associates Health Resources and Services David Gross Administration College of American Pathologists Amy Cunniffe Alberto Gutierrez Caris Life Sciences U.S. Food and Drug Bernard Edelman Administration Vietnam Veterans of America Chris Havasy Russel Enns Presidential Commission for the Cepheid Study of Bioethical Issues W. Gregory Feero Daniel Hayes National Human Genome Research University of Michigan Institute Comprehensive Cancer Center Andrew Freedman C. J. Hoban National Cancer Institute Multiple Myeloma Research Foundation Geoffrey Ginsburg Louis Hochheiser Duke University Humana, Inc.

OCR for page 79
81 APPENDIX D Richard Hodes Emily Lenneville National Institute on Aging Institute of Medicine Gillian Hooker Debra Leonard National Human Genome Research Weill Cornell Medical Center Institute Hallie Lewis Louis Jacques Cepheid Centers for Medicare & Medicaid Rachel Lindor Services Department of Health and Human Janet Jenkins-Showalter Services Roche/Genentech Kimberly Linthicum Michael Evan Johnson Myriad Genetic Laboratories SWIDE Effects LLC Paul Lipkin Sharon Kardia Kennedy Krieger Institute University of Michigan Michele Lloyd-Puryear James Kelly Office of Rare Diseases Research, Affymetrix National Institutes of Health Mohamed Khan Jenny Luray Vancouver Cancer Centre BD Christopher Khoury Anthony Magliocco PwC H. Lee Moffitt Cancer Center Muin Khoury Debra Mathews Centers for Disease Control and Presidential Commission for the Prevention Study of Bioethical Issues Vanessa King Robert McCormack Siemens Corporate Research Veridex, LLC Brenda Kostelecky Mary McGrane National Cancer Institute U.S. Department of Agriculture Jennifer Leib Kasinathan Muralidharan HealthFutures, LLC Quest Diagnostics Nichols Institute

OCR for page 79
82 GENOME-BASED DIAGNOSTICS Rachel Novak Turna Ray U.S. Food and Drug GenomeWeb Administration Michael Reiner Robert Nussbaum Siemens Healthcare University of California, San Stephen Richardson Francisco, School of Medicine Genomic Health, Inc. Steve Olson Allen Roses Independent Consultant Duke University Danielle Pambianco Tharini Sathiamoorthy HillCo HEALTH AdvaMedDx Meeta Patnaik Manon Schladen Transtek Clinical Systems Medstar Health Research Institute Mary Pendergast Kevin Schulman Pendergast Consulting Duke University Medical Center Michelle Penny Joan Scott Eli Lilly and Company National Coalition for Health Margaret Piper Professional Education in Blue Cross and Blue Shield Genetics Association Beverlyn Settles-Reaves Laura Povlich Howard University American Association for the Steven Shak Advancement of Science Congressional Fellow—Office Genomic Health, Inc. of Rep. Sander Levin Fay Shamanski Aidan Power College of American Pathologists Pfizer Inc. Marilee Shelton-Davenport Bruce Quinn National Research Council Foley Hoag LLP Sophie Shen Scott Rabuka The Brookings Institution DNA Genotek Vaidehi Sheth Genetic Alliance

OCR for page 79
83 APPENDIX D Andy Shih Michael S. Watson Autism Speaks American College of Medical Genetics and Genomics Sue Siegel Jennifer Webster Mohr Davidow Kaiser Permanente Center for Jennifer Skornik Heath Research Independent Susan Weiner Dennis Strickland Children’s Cause for Cancer Pfizer Inc. Advocacy Katherine Johansen Taber Cole Werble American Medical Association The RPM Report Wendy Toler Catherine Wicklund Medscientia Northwestern University Sean Tunis Yining Xie Center for Medical Technology National Institutes of Health Policy Huichun Xu Martha Turner National Institutes of Health American Nurses Association Jiwen Zhang Laura van ‘t Veer GE Healthcare University of California, San Francisco, Helen Diller Family Comprehensive Cancer Center

OCR for page 79